Prelude Therapeutics Incorporated (PRLD)
NASDAQ·Healthcare·Biotechnology
$4.29
-5.20%
Mkt Cap $170.52M
Mkt Cap
$170.52M
P/E
—
Fwd P/E
—
P/S
20.15
Rev TTM
—
EPS TTM
-$1.58
NASDAQ·Healthcare·Biotechnology
$4.29
-5.20%
Mkt Cap $170.52M
Mkt Cap
$170.52M
P/E
—
Fwd P/E
—
P/S
20.15
Rev TTM
—
EPS TTM
-$1.58